GAMBACORTI PASSERINI CARLO
- U08, Floor: 4, Room: 4-12
- U08, Floor: 4, Room: 4041
Publications
Duca, F., Manghisi, B., Palasciano, A., Mochi, A., Parma, M., Greco, R., et al. (2026). DNMT3A Co-Mutation and Real-World Clinical Outcomes With Gilteritinib in FLT3-Mutated Acute Myeloid Leukaemia Across Molecular Subgroups. EJHAEM, 7(4) [10.1002/jha2.70374]. Detail
Civettini, I., Malighetti, F., Villa, M., Crippa, V., Aroldi, A., Cavalca, F., et al. (2026). Prognostic Score for Myelodysplastic Syndromes Based on Molecular Evolution. NEJM EVIDENCE, 5(6), 1-13 [10.1056/evidoa2500124]. Detail
Kogan, M., Alviano, A., Catalano, M., Casiraghi, A., Ghilardi, G., Rindone, G., et al. (2025). Remission of low-grade lymphomatoid granulomatosis with extensive pulmonary involvement following immune restoration via antiretroviral therapy in a newly diagnosed HIV patient. AIDS RESEARCH AND THERAPY, 22(1) [10.1186/s12981-025-00717-9]. Detail
Frustaci, A., Zappaterra, A., Turri, G., Rossi, V., Deodato, M., Gambacorti‐passerini, C., et al. (2025). Pirtobrutinib is an Effective Salvage Treatment After Ibrutinib in Bing–Neel Syndrome. AMERICAN JOURNAL OF HEMATOLOGY, 100(10), 1878-1881 [10.1002/ajh.27759]. Detail
Gambacorti-Passerini, C., Bassi, G., Bonfanti, S., Duca, F., Piazza, R., Lattuada, E., et al. (2025). Reconstructing CML guidelines for first line treatment from two different points of view. BLOOD CANCER JOURNAL, 15(1) [10.1038/s41408-025-01331-8]. Detail
Research projects
Awards
Awards
- ABILITAZIONE SCIENTIFICA NAZIONALE A PROFESSORE DI I FASCIA, SSD MED015, MIUR, 2013
Research and teaching assignments
- Docente a contratto - Professor of Oncology and hematology, Canada research Chair, Dept of Oncology, Jewish General Hospital, Montreal, Canadà - McGill University, 2003 - 2008
Congresses/Conferences
- Program chair - 5th ERIA meeting, "20 year of anniversary of the discovery of ALK", 2014